期刊文献+

伴活动性小管间质病变的IgA肾病的临床及病理分析 被引量:4

Clinical and pathology features of IgA nephropathy with active tubular interstitial lesions
原文传递
导出
摘要 目的探讨伴活动性小管间质病变的IgA肾病的临床表现和病理特点。方法回顾性分析本院2014年3月至2015年12月经肾活检确诊且具有完整临床资料的148例IgA肾病患者,其中伴活动性小管间质病变的IgA肾病23例(IgAN-ATIL组),与另外125例IgA肾病患者(对照组)比较,分析其临床及病理特点并对有统计学意义的指标进行多因素Logistic回归分析。结果伴活动性小管间质病变的IgA肾病占IgA肾病的15.5%;与对照组比较,IgAN—ATIL组发病年龄较大(P=0.007);有抗生素、利尿剂、非甾体抗炎药(NSAIDs)等药物使用史患者所占比例较高(P〈0.001);血清白蛋白(P=O.018)、eGFR(P=0.013)较低,肌酐(P=0.009)、尿素氮(P=0.003)、24h尿蛋白量(P=0.011)、尿中性粒细胞明胶酶相关载脂蛋白(neutrophilgelatinase—associated lipocalin,NAGL)(P〈0.001)、尿红细胞计数(P=0.007)较高;Lee分级等级较高,肾小管间质慢性病变以中度为主,而对照组以轻度为主。多因素分析提示年龄、用药史、尿NGAL是IgA肾病小管间质活动性病变的独立影响因素。结论伴活动性小管间质病变的IgA肾病患者较一般IgA肾病患者有更重的临床表现以及小管间质慢性病变,临床上应尽早干预;年龄、用药史(抗生素、利尿剂、NSAIDs等)、尿NGAL是IgA肾病小管间质活动性病变的独立影响因素。 Objective To investigate the clinical and pathological characteristics of IgA nephropathy (IgAN) in association with active tubular interstitial lesions. Methods 148 patients who were diagnosed as IgAN by renal biopsy and admitted to Zhejiang Provincial People's Hospital from March 2014 to December 2014 were enrolled. They were divided into IgAN with active tubular interstitial lesions group (IgAN-ATIL group, 23 patients) and IgAN without active tubular interstitial lesions group (control group, 125 patients). Clinical and pathological characteristics were retrospectively analyzed. Multivariate logistic regression analysis was used to analyze the influence factors. Results The prevalence of ATIL in 148 IgAN patients was 15.5%. IgAN-ATIL group showed an older average age and more higher proportion of medication history (antibiotics, diuretics, nonsteroidal antiinflammatory drugs, etc) than those in control group. There were significant differences in Alb, eGFR, Scr, BUN, 24-hour urinary protein quantity, urinary NGAL and urinary RBC count between two groups (P 〈 0.05, respectively). A moderate of tubulointerstitial lesions of IgAN-ATIL group was shown, while the control group was mainly mild lesions. Multivariate logistic regression analysis showed that age, medication history and the urinary NGAL level were independent risk factors of IgAN- ATIL. Conclusions IgAN patients with active tubular interstitial lesions had more severe clinical manifestations and chronic interstitial lesions. The age, medication history (antibiotics, diuretics, nonsteroidal anti-inflammatory drugs, etc) and the urinary NGAL level were independent risk factors of IgAN-ATIL.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2016年第10期728-733,共6页 Chinese Journal of Nephrology
基金 浙江省中医药管理局项目(2016ZA023) 浙江省科技厅重大专项(2014C03047-2) 浙江省自然基金项目(LYl6H050005) 卫生高层次医坛新秀人才培养工程项目(2013)
关键词 肾小球肾炎 IgA 病理学 临床 活动性病变 Glomerulonephritis, IgA Pathology, clinical Active tubular interstitial lesions
  • 相关文献

参考文献13

  • 1Wyatt RJ, Julian BA. IgA nephropathy[J].N Engl J Med, 2013,368(25): 2402-2414. DOI: 10.1056/NEJMral206793.
  • 2Li LS, Liu ZH. Epidemiologic data of renal diseases from asingle unit in China: analysis based on 13,519 renal biopsies[J].Kidney Int, 2004, 66(3): 920-923. DOI: 10.1111/j.l523-1755.2004.00837.x.
  • 3邹万忠,王海燕.肾活检病理学[M].第3版.北京:北京大学医学出版社,2014.
  • 4刘亚红,苑丽华.尿沉渣联合尿KIM-1、NGAL在诊断原发性肾脏病合并急性肾小管间质病变中的意义[J].国际泌尿系统杂志,2015,35(2):176-179. 被引量:8
  • 5Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy:morphologic predictors of progressive renal disease[J].HumPathol, 1982, 13(4): 314-322.
  • 6Roberts IS, Cook HT, Troyanov S, et al. The Oxfordclassification of IgA nephropathy: pathology definitions,correlations, and reproducibility[J].Kidney Int, 2009, 76(5):546-556. DOI: 10.1038/ki.2009.168.
  • 7Lv J, Shi S, Xu D, et al. Evaluation of the OxfordClassification of IgA nephropathy: a systematic review and meta-analysis[J].Am J Kidney Dis, 2013,62(5): 891 -899. DOI:10.1053/j.ajkd.2013.04.021.
  • 8Muriithi AK, Leung N, Valeri AM, et al. Clinicalcharacteristics, causes and outcomes of acute interstitialnephritis in the elderly[J].Kidney Int, 2015, 87(2): 458-464.DOI: 10.1038/ki.2014.294.
  • 9Goicoechea M, Rivera F, L6pez - G6mez JM. Increasedprevalence of acute tubulointerstitial nephritis[J].Nephrol DialTransplant, 2013,28(1): 112-115. DOI: 10.1093/ndt/gfsl43.
  • 10Antonucci E, Lippi G, Ticinesi A, et al. Neutrophil gelatinase -associated lipocalin (NGAL): a promising biomarker for theearly diagnosis of acute kidney injury (AKI) [J].Acta Biomed,2014,85(3): 289-294.

二级参考文献9

  • 1Waikar SS, Bonventre JV. Biomarkers for the diagnosis of acute kid- ney injury[ J ]. Curr Opin Nephrol Hypertens ,2007,16:557 - 564.
  • 2Perazella MA, Coca SG, Hall IE, et al. Urine microscopy is asso- ciated with severity and worsening of acute kidney injury inhospital- ized patients [ J ]. Clin J Am Soc Nephrol, 2010, 5 : 402 - 408.
  • 3MoriK, LeeH T, Rapoport D, et al. Endocytic delivery of lipocalinsid erophore - iron complex rescures the kidney from ischemia - reper- fusion injury [ J ]. J Clin Invest,2005,115 ( 3 ) : 610 - 621.
  • 4Wu I,Parikh CR. Screening for kidney diseases older measures ver- sus novel biomarkers [ J ]. Clin J Am Soc Nephrol, 2008,3 ( 6 ) : 1895 - 1901.
  • 5Han WK, Bailly V, Abichandani R, et al. Kidney injury molecule - 1 ( KIM - 1 ) : A novel biomarker for human renal proximal tubule injury [ J ]. Kidney Int,2002,62 ( 1 ) :237 - 244.
  • 6Chaturvedi S, Farmer T, Kapke GF. Assay validation for KIM - 1 : human urinary renal dysfunction biomarker [ J]. Int J Biol Sci, 2009,5(2) : 128 - 134.
  • 7van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule - 1 ( KIM - 1 ) in human renal disease[ J]. J Pathol,2007,212(2) :209 -217.
  • 8Schentag JJ, Gengo FM, PlautME, et al. Urinary casts as an indi- cator of renal tubular damage in patients receiving aminoglycosides [ J ]. Antimicrob Agents Chemother, 1979, 16 : 468 - 474.
  • 9汤天凤,郑春霞,尹茹,张炯,刘志红.肾小管损伤标志物在局灶节段性肾小球硬化患者中的变化及意义[J].肾脏病与透析肾移植杂志,2010(4):317-323. 被引量:18

共引文献7

同被引文献28

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部